(VIANEWS) – Fortress Biotech (FBIOP), National Health Investors (NHI), Ivy High Income Opportunities Fund (IVH) have the highest dividend yield stocks on this list.
| Financial Asset | Forward Dividend Yield | Updated (EST) |
|---|---|---|
| Fortress Biotech (FBIOP) | 12.82% | 2023-04-09 01:08:07 |
| National Health Investors (NHI) | 7.24% | 2023-03-30 03:07:07 |
| Ivy High Income Opportunities Fund (IVH) | 6.18% | 2023-03-29 04:42:16 |
| Swiss Helvetia Fund (SWZ) | 6.03% | 2023-03-31 07:47:19 |
| Best Buy Co. (BBY) | 4.14% | 2023-04-12 13:46:35 |
| Haverty Furniture Companies (HVT) | 3.58% | 2023-03-29 01:10:08 |
| Camden Property Trust (CPT) | 3.13% | 2023-03-27 16:41:19 |
| Procter & Gamble (PG) | 2.64% | 2023-04-12 13:43:49 |
| McDonald’s Corporation (MCD) | 2.33% | 2023-04-12 13:51:35 |
Close to 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. Fortress Biotech (FBIOP) – Dividend Yield: 12.82%
Fortress Biotech’s last close was $18.28, 23.83% below its 52-week high of $24.00. Intraday change was 0.05%.
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin conditions; Luxamend for dressing and managing wounds; and Accutane capsules for severe recalcitrant nodular acne. It also develops late stage product candidates, such as intravenous Tramadol for the treatment of post-operative acute pain; CUTX-101, an injection for the treatment of Menkes disease; MB-107 and MB-207 for the treatment of X-linked severe combined immunodeficiency; Cosibelimab for metastatic cancers; CK-101 for the treatment of patients with EGFR mutation-positive NSCLC; CAEL-101 for the treatment of amyloid light chain amyloidosis; Triplex vaccine for cytomegalovirus; and CEVA101 for the treatment of severe traumatic brain injury in adults and children. The company's early stage product candidates include MB-102 for blastic plasmacytoid dendritic cell neoplasm; MB-101 for glioblastoma; MB-104 for multiple myeloma and light chain amyloidosis; MB-106 for B-cell non-hodgkin lymphoma; MB-103 for GBM & metastatic breast cancer to brain; MB-108; MB-105 for prostate and pancreatic cancers; and BAER-101. Its preclinical product candidates comprise AAV-ATP7A gene therapy; AVTS-001 gene therapy; CK-103 BET inhibitor; CEVA-D and CEVA-102; CK-302, an anti-GITR; CK-303, an anti-CAIX; ConVax; and ONCOlogues, and oligonucleotide platform. It has collaboration arrangements with universities, research institutes, and pharmaceutical companies. The company was formerly known as Coronado Biosciences, Inc. and changed its name to Fortress Biotech, Inc. in April 2015. Fortress Biotech, Inc. was incorporated in 2006 and is based in New York, New York.
Earnings Per Share
As for profitability, Fortress Biotech has a trailing twelve months EPS of $-0.86.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -155.06%.
More news about Fortress Biotech.
2. National Health Investors (NHI) – Dividend Yield: 7.24%
National Health Investors’s last close was $50.64, 24.6% under its 52-week high of $67.16. Intraday change was 1.79%.
Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
Earnings Per Share
As for profitability, National Health Investors has a trailing twelve months EPS of $1.48.
PE Ratio
National Health Investors has a trailing twelve months price to earnings ratio of 34.22. Meaning, the purchaser of the share is investing $34.22 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.67%.
Sales Growth
National Health Investors’s sales growth is 8% for the current quarter and 28.8% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 0.4%, now sitting on 278.76M for the twelve trailing months.
Moving Average
National Health Investors’s value is below its 50-day moving average of $54.80 and way below its 200-day moving average of $57.73.
More news about National Health Investors.
3. Ivy High Income Opportunities Fund (IVH) – Dividend Yield: 6.18%
Ivy High Income Opportunities Fund’s last close was $11.18, 12.79% under its 52-week high of $12.82. Intraday change was -3.54%.
Ivy Funds – Ivy High Income Opportunities Fund is a closed ended fixed income mutual fund launched and managed by Ivy Investment Management Company. The fund invests in fixed income markets across the globe. It seeks to invest in securities of companies operating across diversified sectors. The fund primarily invests in high-yield corporate bonds of various maturities, secured loans, and other corporate fixed-income instruments, which are rated below investment grade (below Baa3 by Moody's or below BBB- by either S&P or Fitch). Ivy Funds – Ivy High Income Opportunities Fund was formed on May 29, 2013 and is domiciled in the United States.
Yearly Top and Bottom Value
Ivy High Income Opportunities Fund’s stock is valued at $11.18 at 20:15 EST, way under its 52-week high of $12.82 and way higher than its 52-week low of $9.99.
More news about Ivy High Income Opportunities Fund.
4. Swiss Helvetia Fund (SWZ) – Dividend Yield: 6.03%
Swiss Helvetia Fund’s last close was $7.83, 17.58% below its 52-week high of $9.50. Intraday change was 1.03%.
The Swiss Helvetia Fund Inc. is a closed-ended equity mutual fund launched and managed by Schroder Investment Management North America Inc. The fund invests in public equity markets of Switzerland. It seeks to invest in stocks of companies operating across diversified sectors. The fund primarily invests in value stocks of companies across all market capitalizations. It employs fundamental analysis with a bottom-up stock picking approach, focusing on factors such as capital appreciation, income, economic and industry trends, quality of management, financial condition, business plan, industry and sector market position, dividend payout ratio, and corporate governance to create its portfolio. The fund benchmarks the performance of its portfolio against the S&P 500 Index and MSCI EAFE Index. It was previously known as The Helvetia Fund, Inc. The Swiss Helvetia Fund Inc. was formed in October 24, 1986 and is domiciled in the United States.
Earnings Per Share
As for profitability, Swiss Helvetia Fund has a trailing twelve months EPS of $1.29.
PE Ratio
Swiss Helvetia Fund has a trailing twelve months price to earnings ratio of 6.08. Meaning, the purchaser of the share is investing $6.08 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -17.56%.
Volume
Today’s last reported volume for Swiss Helvetia Fund is 36199 which is 88.09% above its average volume of 19245.
Revenue Growth
Year-on-year quarterly revenue growth grew by 8.3%, now sitting on 2.91M for the twelve trailing months.
Yearly Top and Bottom Value
Swiss Helvetia Fund’s stock is valued at $7.83 at 20:15 EST, way below its 52-week high of $9.50 and way higher than its 52-week low of $6.56.
Moving Average
Swiss Helvetia Fund’s value is under its 50-day moving average of $7.88 and above its 200-day moving average of $7.64.
More news about Swiss Helvetia Fund.
5. Best Buy Co. (BBY) – Dividend Yield: 4.14%
Best Buy Co.’s last close was $75.25, 25.44% below its 52-week high of $100.93. Intraday change was -2.1%.
Best Buy Co., Inc. engages in the retail of technology products in the United States and Canada. The company operates in two segments, Domestic and International. Its stores provide computing and mobile phone products, such as desktops, notebooks, and peripherals; mobile phones comprising related mobile network carrier commissions; networking products; tablets covering e-readers; smartwatches; and consumer electronics consisting of digital imaging, health and fitness products, home theater, portable audio comprising headphones and portable speakers, and smart home products. The company's stores also offer appliances, such as dishwashers, laundry, ovens, refrigerators, blenders, coffee makers, and vacuums; entertainment products consisting of drones, peripherals, movies, music, and toys, as well as gaming hardware and software, and virtual reality and other software products; and other products, such as baby, food and beverage, luggage, outdoor living, and sporting goods. In addition, it provides consultation, delivery, design, installation, memberships, repair, set-up, technical support, health-related, and warranty-related services. The company offers its products through stores and websites under the Best Buy, Best Buy Ads, Best Buy Business, Best Buy Health, Buy Mobile, CST, Current Health, Geek Squad, Lively, Magnolia, Pacific Kitchen, Home, TechLiquidators, and Yardbird brands, as well as domain names comprising bestbuy.com, currenthealth.com, lively.com, techliquidators.com, yardbird.com, and bestbuy.ca. The company was formerly known as Sound of Music, Inc. Best Buy Co., Inc. was incorporated in 1966 and is headquartered in Richfield, Minnesota.
Earnings Per Share
As for profitability, Best Buy Co. has a trailing twelve months EPS of $6.29.
PE Ratio
Best Buy Co. has a trailing twelve months price to earnings ratio of 11.71. Meaning, the purchaser of the share is investing $11.71 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 42.63%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 23.1% and a negative 7%, respectively.
Volatility
Best Buy Co.’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.63%, a negative 0.32%, and a positive 1.42%.
Best Buy Co.’s highest amplitude of average volatility was 0.78% (last week), 1.46% (last month), and 1.42% (last quarter).
Moving Average
Best Buy Co.’s value is way under its 50-day moving average of $83.06 and under its 200-day moving average of $76.22.
Volume
Today’s last reported volume for Best Buy Co. is 928933 which is 61.48% below its average volume of 2411660.
More news about Best Buy Co..
6. Haverty Furniture Companies (HVT) – Dividend Yield: 3.58%
Haverty Furniture Companies’s last close was $31.30, 19.43% below its 52-week high of $38.85. Intraday change was 0.06%.
Haverty Furniture Companies, Inc. operates as a specialty retailer of residential furniture and accessories in the United States. The company offers furniture merchandise under the Havertys brand name. It also provides custom upholstery products and eclectic looks; and mattress product lines under the Sealy, Stearns and Foster, Tempur-Pedic, and Serta names, as well as private label Skye name. The company sells home furnishings through its retail stores, as well as through its Website. As of December 31, 2021, it operated 121 showrooms in 16 states in the Southern and Midwestern regions. Haverty Furniture Companies, Inc. was founded in 1885 and is headquartered in Atlanta, Georgia.
Earnings Per Share
As for profitability, Haverty Furniture Companies has a trailing twelve months EPS of $5.24.
PE Ratio
Haverty Furniture Companies has a trailing twelve months price to earnings ratio of 5.97. Meaning, the purchaser of the share is investing $5.97 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 32.77%.
More news about Haverty Furniture Companies.
7. Camden Property Trust (CPT) – Dividend Yield: 3.13%
Camden Property Trust’s last close was $99.89, 43.14% under its 52-week high of $175.69. Intraday change was 0.11%.
Camden Property Trust, an S&P 400 Company, is a real estate company primarily engaged in the ownership, management, development, redevelopment, acquisition, and construction of multifamily apartment communities. Camden owns interests in and operates 167 properties containing 56,850 apartment homes across the United States. Upon completion of 7 properties currently under development, the Company's portfolio will increase to 59,104 apartment homes in 174 properties. Camden has been recognized as one of the 100 Best Companies to Work For® by FORTUNE magazine for 13 consecutive years, most recently ranking #18. The Company also received a Glassdoor Employees' Choice Award in 2020, ranking #25 for large U.S. companies.
Earnings Per Share
As for profitability, Camden Property Trust has a trailing twelve months EPS of $1.12.
PE Ratio
Camden Property Trust has a trailing twelve months price to earnings ratio of 89.29. Meaning, the purchaser of the share is investing $89.29 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.19%.
Volume
Today’s last reported volume for Camden Property Trust is 791490 which is 14.49% below its average volume of 925686.
Moving Average
Camden Property Trust’s worth is way under its 50-day moving average of $115.31 and way below its 200-day moving average of $122.14.
More news about Camden Property Trust.
8. Procter & Gamble (PG) – Dividend Yield: 2.64%
Procter & Gamble’s last close was $150.66, 8.64% under its 52-week high of $164.90. Intraday change was 0.76%.
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands. The Grooming segment provides shave care products and appliances under the Braun, Gillette, and Venus brand names. The Health Care segment offers toothbrushes, toothpastes, and other oral care products under the Crest and Oral-B brand names; and gastrointestinal, rapid diagnostics, respiratory, vitamins/minerals/supplements, pain relief, and other personal health care products under the Metamucil, Neurobion, Pepto-Bismol, and Vicks brands. The Fabric & Home Care segment provides fabric enhancers, laundry additives, and laundry detergents under the Ariel, Downy, Gain, and Tide brands; and air care, dish care, P&G professional, and surface care products under the Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer brands. The Baby, Feminine & Family Care segment offers baby wipes, taped diapers, and pants under the Luvs and Pampers brands; adult incontinence and feminine care products under the Always, Always Discreet, and Tampax brands; and paper towels, tissues, and toilet papers under the Bounty, Charmin, and Puffs brands. The company sells its products primarily through mass merchandisers, e-commerce, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, specialty beauty stores, high-frequency stores, pharmacies, electronics stores, and professional channels, as well as directly to consumers. The Procter & Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio.
Earnings Per Share
As for profitability, Procter & Gamble has a trailing twelve months EPS of $5.71.
PE Ratio
Procter & Gamble has a trailing twelve months price to earnings ratio of 26.58. Meaning, the purchaser of the share is investing $26.58 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 32.02%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jan 18, 2023, the estimated forward annual dividend rate is 3.65 and the estimated forward annual dividend yield is 2.64%.
Moving Average
Procter & Gamble’s value is above its 50-day moving average of $141.20 and above its 200-day moving average of $141.58.
More news about Procter & Gamble.
9. McDonald’s Corporation (MCD) – Dividend Yield: 2.33%
McDonald’s Corporation’s last close was $284.48, 1% higher than its 52-week high of $281.67. Intraday change was 0.35%.
McDonald's Corporation operates and franchises McDonald's restaurants in the United States and internationally. Its restaurants offer hamburgers and cheeseburgers, chicken sandwiches and nuggets, wraps, fries, salads, oatmeal, shakes, desserts, sundaes, soft serve cones, bakery items, soft drinks, coffee, and beverages and other beverages, as well as breakfast menu, including biscuit and bagel sandwiches, breakfast burritos, hotcakes, and other sandwiches. As of December 31, 2021, the company operated 40,031 restaurants. McDonald's Corporation was founded in 1940 and is headquartered in Chicago, Illinois.
Earnings Per Share
As for profitability, McDonald’s Corporation has a trailing twelve months EPS of $8.34.
PE Ratio
McDonald’s Corporation has a trailing twelve months price to earnings ratio of 34.23. Meaning, the purchaser of the share is investing $34.23 for every dollar of annual earnings.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, McDonald’s Corporation’s stock is considered to be oversold (<=20).
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 0.9% and 4.3%, respectively.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Feb 27, 2023, the estimated forward annual dividend rate is 6.08 and the estimated forward annual dividend yield is 2.33%.
More news about McDonald’s Corporation.
